| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
in Colorectal Cancer Generates an Increased Proteolytic Potential in the Stroma1
Institute of Biochemistry and Molecular Biology [D. L., D. H., E. E. S.], and Department of Visceral and Transplantation Surgery [C. A. M., M. W. B.], Inselspital, University of Bern, 3000 Bern, Switzerland
Epithelial cells of the normal human colonic mucosa secrete an astacin-type metalloprotease, meprin
(E. C. 3.4.24.18, N-benzoyl-L-tyrosyl-p-aminobenzoic acid hydrolase), into the intestinal lumen. We found that Caco-2 cells, a colon carcinoma cell line, expressed endogenous meprin
, which was secreted at both the basolateral and apical plasma membrane. The expression of meprin
in colorectal cancer was confirmed using Northern blot analysis. On tissue sections, a diversity of carcinoma cells with varying immunoreactivity for meprin
was observed. Western blots of a series of 11 paired samples of carcinomas and normal control colon tissue revealed that meprin
protein accumulated at significant levels in 6 carcinomas at Union International Contre le Cancer tumor stages IIV. In contrast, the protease was never detected in normal control tissue samples. Meprin
zymogen was activated in the tumor tissue, as shown by a 3-fold increase in enzymatic activity. In conclusion, we describe a cancer-specific sorting of meprin
, leading to a redistribution with consecutively increased proteolytic activity in the tumor stroma. Because the protease is known to cleave extracellular matrix components in vitro, meprin
may contribute to tumor progression by facilitating migration, intravasation, and metastasis of carcinoma cells.
This article has been cited by other articles:
![]() |
D. A. Bergin, C. M. Greene, E. E. Sterchi, C. Kenna, P. Geraghty, A. Belaaouaj, C. C. Taggart, S. J. O'Neill, and N. G. McElvaney Activation of the Epidermal Growth Factor Receptor (EGFR) by a Novel Metalloprotease Pathway J. Biol. Chem., November 14, 2008; 283(46): 31736 - 31744. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sabo, P. A. Meitner, R. Tavares, C. L. Corless, G. Y. Lauwers, S. F. Moss, and M. B. Resnick Expression Analysis of Barrett's Esophagus-Associated High-Grade Dysplasia in Laser Capture Microdissected Archival Tissue Clin. Cancer Res., October 15, 2008; 14(20): 6440 - 6448. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A Heinzelmann-Schwarz, R. A Scolyer, J. P Scurry, A. N Smith, M. Gardiner-Garden, A. V Biankin, S. Baron-Hay, C. Scott, R. L Ward, D. Fink, et al. Low meprin {alpha} expression differentiates primary ovarian mucinous carcinoma from gastrointestinal cancers that commonly metastasise to the ovaries J. Clin. Pathol., June 1, 2007; 60(6): 622 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Ishmael, F. T. Ishmael, A. D. Jones, and J. S. Bond Protease Domain Glycans Affect Oligomerization, Disulfide Bond Formation, and Stability of the Meprin A Metalloprotease Homo-oligomer J. Biol. Chem., December 8, 2006; 281(49): 37404 - 37415. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hirano, B. Y. Ma, N. Kawasaki, K. Okimura, M. Baba, T. Nakagawa, K. Miwa, N. Kawasaki, S. Oka, and T. Kawasaki Mannan-Binding Protein Blocks the Activation of Metalloproteases Meprin {alpha} and {beta} J. Immunol., September 1, 2005; 175(5): 3177 - 3185. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Quesada, L. M. Sanchez, J. Alvarez, and C. Lopez-Otin Identification and Characterization of Human and Mouse Ovastacin: A NOVEL METALLOPROTEINASE SIMILAR TO HATCHING ENZYMES FROM ARTHROPODS, BIRDS, AMPHIBIANS, AND FISH J. Biol. Chem., June 18, 2004; 279(25): 26627 - 26634. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hahn, A. Pischitzis, S. Roesmann, M. K. Hansen, B. Leuenberger, U. Luginbuehl, and E. E. Sterchi Phorbol 12-Myristate 13-Acetate-induced Ectodomain Shedding and Phosphorylation of the Human Meprin{beta} Metalloprotease J. Biol. Chem., October 31, 2003; 278(44): 42829 - 42839. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Norman, W. Jiang, X. Han, T. L. Saunders, and J. S. Bond Targeted Disruption of the Meprin {beta} Gene in Mice Leads to Underrepresentation of Knockout Mice and Changes in Renal Gene Expression Profiles Mol. Cell. Biol., February 15, 2003; 23(4): 1221 - 1230. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Bertenshaw, M. T. Norcum, and J. S. Bond Structure of Homo- and Hetero-oligomeric Meprin Metalloproteases. DIMERS, TETRAMERS, AND HIGH MOLECULAR MASS MULTIMERS J. Biol. Chem., January 17, 2003; 278(4): 2522 - 2532. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rosmann, D. Hahn, D. Lottaz, M.-N. Kruse, W. Stocker, and E. E. Sterchi Activation of Human Meprin-alpha in a Cell Culture Model of Colorectal Cancer Is Triggered by the Plasminogen-activating System J. Biol. Chem., October 18, 2002; 277(43): 40650 - 40658. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kadowaki, T. Tsukuba, G. P. Bertenshaw, and J. S. Bond N-Linked Oligosaccharides on the Meprin A Metalloprotease Are Important for Secretion and Enzymatic Activity, but Not for Apical Targeting J. Biol. Chem., August 11, 2000; 275(33): 25577 - 25584. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |